Gotistobart Long Term Extension (LTE) Study

StatusEnrolling by Invitation
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Enrolling by invitation only
    • Start date changed from estimate of Jul 1, 2026 to Jul 28, 2026
    v3
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
OncoC4, Inc.
9 trials monitored
See 2 trials at risk
This LTE study will examine the long-term overall survival and safety of gotistobart in patients with advanced solid tumors.
Trial Details
NCT Number NCT07659379
Lead Sponsor OncoC4, Inc.
Conditions
(from sponsor)		 Advanced Solid Tumor
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov